The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I study evaluating GDC-0941, an oral phosphoinositide-3 kinase (PI3K) inhibitor, in patients with advanced solid tumors or multiple myeloma.
V. Moreno Garcia
Employment or Leadership Position - Institute of Cancer Research
R. D. Baird
Employment or Leadership Position - Institute of Cancer Research
Honoraria - Genentech
K. J. Shah
Employment or Leadership Position - Institute of Cancer Research
B. Basu
Employment or Leadership Position - Institute of Cancer Research
N. Tunariu
Employment or Leadership Position - Institute of Cancer Research
M. Blanco
Employment or Leadership Position - Institute of Cancer Research
P. A. Cassier
Employment or Leadership Position - Institute of Cancer Research
J. V. Pedersen
Employment or Leadership Position - Institute of Cancer Research
M. Puglisi
Employment or Leadership Position - Institute of Cancer Research
D. Sarker
Employment or Leadership Position - Institute of Cancer Research
D. Papadatos-Pastos
Employment or Leadership Position - Institute of Cancer Research
A. G. Omlin
Employment or Leadership Position - Institute of Cancer Research
A. Biondo
Employment or Leadership Position - Institute of Cancer Research
J. A. Ware
Employment or Leadership Position - Genentech
Stock Ownership - Roche
H. Koeppen
Employment or Leadership Position - Genentech
Stock Ownership - Roche
G. G. Levy
Employment or Leadership Position - Genentech
Stock Ownership - Roche
K. E. Mazina
Employment or Leadership Position - Genentech
Stock Ownership - Roche
J. S. De Bono
Employment or Leadership Position - Institute of Cancer Research
Consultant or Advisory Role - Arno Therapeutics; AstraZeneca; Exelixis; Genentech; GlaxoSmithKline; Merck; Novartis; Pfizer
Honoraria - Arno Therapeutics; AstraZeneca; Exelixis; Genentech; GlaxoSmithKline; Merck; Novartis; Pfizer
Research Funding - Phase I Trials of GDC0941